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ABSTRACT 
The solubility of a solute is the maximum quantity of solute that can dissolve in a certain quantity of solvent or quantity of solution at a specified 
temperature. Solubility is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological 
response to be shown. Solubility is essential for the therapeutic effectiveness of the drug, independent of the route of administration. Low 
aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic 
development. Poorly soluble drugs are often a challenging task for formulators in the industry Conventional  approaches  for  enhancement  of  
solubility  have  limited  applicability,  especially when  the  drugs  are  poorly  soluble  simultaneously  in  aqueous  and  in  non-aqueous  media. 
Drug with poor water solubility cause slow dissolution rates, generally show erratic and incomplete absorption leading to low bioavailability 
when administered orally. Solubilization may be affected by cosolvent water  interaction, micellar solubilization, reduction in  particle  size,  
inclusion  complexes,  solid  dispersion,  and  change  in  polymorph.  Some  new technologies  are  also  available  to  increase  the  solubility  like  
micro emulsion,  self-emulsifying drug  delivery  system  and  supercritical  fluid  technology. This present review details about the different 
approaches used for the enhancement of the solubility of poorly water-soluble drugs include particle size reduction, nanonization, pH 
adjustment, solid dispersion, complexation, co‐solvency, hydrotropy etc. The purpose of this article is to describe the techniques of solubilization 
for the attainment of effective absorption and improved bioavailability.  
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INTRODUCTION  
 It has been estimated that nearly 35-40 % of drugs suffer 
from poor aqueous solubility and it affects the absorption of 
drug from gastrointestinal tract that leads to high inter and 
intra subject variability, poor oral bioavailability, increase in 
dose, reduction in therapeutic efficiency and finally failure in 
formulation development2,4. Various formulation strategies 
like micronization, solubilization, complexation, dendrimers 
for drug solubilization, formation of solid 
solutions/dispersions with hydrophilic carriers, self-micro 
emulsifying drug delivery systems (SMEDDS). Nano 
particulate approaches spray drying, pro-drug approaches 
and salt synthesis had been attempted for solubility 
enhancement12. An attractive possibility would be 
represented by implementing a simple solid dispersion 
technique by utilizing several hydrophilic carriers. Such 
technique impart a means of reducing particle size to a 
nearly molecular level, presenting a variety of processing 
and excipients options which allow for flaccidity when 
formulating oral delivery systems of low water soluble drugs 
with cost effectiveness and denoting dose reduction. 
Solubility and dissolution. The solubility behaviour of a drug 
is a crucial determinant of its oral bioavailability1. There 
have been always certain drugs, for which solubility has 
conferred a challenge to the development of a suitable 
formulation for oral administration. With the recent advent 
of high throughput screening of potential therapeutic agents, 
the number of poorly soluble drug moieties has increased 
suddenly and thus the formulation of poorly soluble 
compounds for oral delivery now presents one of the most 
frequent and greatest challenges to formulation scientists in 
the pharmaceutical industry6. The free energy (G) is a 
measure of the energy available to the system to perform 
work. Its value decreases during a continuously occurring 
process unless and until an equilibrium position is achieved 
when no further energy can be made available, i.e., ΔG=0 at 
equilibrium2,3,5. The solution was developed when 
equilibrium is established between un-dissolved and 
dissolved solute components in a dissolution process is 
termed as saturated solution. The amount of substance that 
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passes into solution in order to establish the equilibrium at 
constant pressure and temperature and so produced a 
saturated solution is known as the solubility of the 
Consideration of the modified Noyes-Whitney equation 
provides some hints as to how the dissolution rate of even 
very poorly soluble compounds might be improved to 
minimize the limitations to oral bioavailability of 
substance5,6. 
dC/dt = AD (Cs - C)/h 
Where, dC/dt is the rate of dissolution, A is the surface area 
available for dissolution, D is the diffusion coefficient of the 
compound, Cs is the solubility of the compound in a 
dissolution medium, C is the concentration of drug present in 
the medium at a time t and h is the thickness of the diffusion 
boundary layer adjacent to the surface of the dissolving 
compound12.The main possibilities or improving dissolution 
according to this analysis are to increase the surface area 
available for dissolution by decreasing the size of the 
particles present in the solid compound by optimizing the 
wetting phenomenon of the compound surface, to decrease 
the boundary layer thickness, to ensure sink conditions for 
dissolution and, last but not definitely the least, to enhance 
the apparent solubility of the drug molecules under 
physiologically relevant conditions11,16. The absorption of 
drug from the gastrointestinal (GI) tract can be limited by 
several factors with the most important contributors being 
poor aqueous solubility and/or poor membrane 
permeability of the drug molecule. While delivering an active 
agent orally, it is very much important that it must dissolve 
in gastric and/or intestinal fluids before it can reach 
systemic circulation through GI membrane permeability. 
Hence, a drug with poor aqueous solubility will exhibit 
dissolution rate limited absorption, and a drug with poor 
membrane permeability will basically exhibit permeation 
rate limited absorption. Thus, two areas of pharmaceutical 
research that focus on improving the oral bioavailability of 
the active agents include enhancing solubility and 
dissolution rate of poorly water-soluble drugs and increasing 
the permeability of poorly permeable drugs. Several 
Approaches for enhancement of drug dissolution/ 
bioavailability of poorly soluble drugs17,43 
I. PHYSICAL MODIFICATIONS 15,18 
 Particle size 
 Micronization 
 Nanoionization 
 Modifications of the crystal habit  
 Polymorphs  
 Pseudo polymorphs (including solvates)  
 Complexation/solubilization 
 Utilization of surfactants 
 Utilization of cyclodextrines 
 Dispersion of Drug in a carrier  
 Solid dispersions (non-molecular)  
 Solid solutions  
II. Chemical modifications 22,26 
 Salt formation 
 Co Solvency 
 Co-Crystallization 
 Nano technology 
 Hydrotrophy 
 Solubilizing Agent  
III. Other 17,19 
 Hot Melt Extrusion 
 High Pressure Homogenization 
 Solvent Evaporation Method  
 Polymeric Alteration 
 Super Critical Method 
 Electrostatic Sppining Method 
 Spray Freezing in to liquid & Lyphophillization Tech. 
 Lyphophilization Tech. 
 Direct Capsule Filling  
 Inclusion Complexes 
 Kneading Method 
 Co-precipitation  
 Spray Drying 
Physical Modifications 
(a) Particle Size Reduction  
The solubility of drug is often intrinsically related to drug 
particle size; as a particle becomes smaller, the surface area 
to volume ratio increases. The larger surface area allows 
greater interaction with the solvent which causes an increase 
in solubility. Conventional methods of particle size reduction, 
such as comminution and spray drying, rely upon mechanical 
stress to disaggregate the active compound14,18. Particle size 
reduction is thus permitting an efficient, reproducible, and 
economic means of solubility enhancement. However, the 
mechanical forces inherent to comminution, such as milling 
and grinding, often impart significant amounts of physical 
stress upon the drug product which may induce degradation. 
The thermal stress which may occur during comminution 
and spray drying is also a concern when processing thermo 
sensitive or unstable active compounds. Using traditional 
approaches for nearly insoluble drugs may not be able to 
enhance the solubility up to desired level8,29.  
(b) Micronization 
Micronization is another conventional technique for the 
particle size reduction. Micronization increases the 
dissolution rate of drugs through increased surface area, it 
does not increase equilibrium solubility. Decreasing the 
particle size of these drugs, which cause increase in surface 
area, improve their rate of dissolution. Micronization of 
drugs is done by milling techniques using jet mill, rotor 
stator colloid mills and so forth micronization is not suitable 
for drugs having a high dose number because it does not 
change the saturation solubility of the drug13,14. 
(c) Nanosuspension 
Nanosuspension technology is important tool for solubility 
enhancement of poorly soluble drug. A pharmaceutical 
nanosuspension is defined as very finely dispersed solid 
drug particles in an aqueous vehicle for either oral and 
topical use or parenteral and pulmonary administration. The 
particle size distribution of the solid particles in 
nanosuspensions is between 200 and 600 nm12,42. In 
nanosuspension the particle size of drug reduce which 
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increase the surface area and therefore the dissolution rate 
and solubility increases which enhance bioavailability. 
Basically Nanosuspension is submicron colloidal dispersion 
of pure particles of drug which is stabilized by surfactants. 
Compounds that are insoluble in water (but are soluble in 
oil) with high log P value, high melting point and high doses 
for that nanosuspension is favourable method. 
Nanosuspension technology can also be applicable for drugs 
which are insoluble in both water and organic solvents16,17,30. 
 Advantages of nanosuspension  
 1. This method improves the solubility and bioavailability of 
drug which gives rapid onset of action. 
 2. To increase the bioavailability of drugs with high log P 
value can be formulated as nanosuspensions. 
 3. Dose reduction is possible. 
(d) Modification of Crystal Habit22 
Polymorphism is the ability of an element or compound to 
crystallize in more than one crystalline form.  Different 
polymorphs  of  drugs  are  chemically identical,  but  they  
exhibit  different physicochemical  properties  including 
solubility, melting  point,  density,  texture, stability41,44.  
Similarly  amorphous  form  of drug  is  always  more  suited  
than crystalline  form  due  to  higher  energy associated  and  
increase  in  surface  area. Order  for  dissolution  of  different  
solid forms of drug.  
Amorphous >Metastable polymorph >Stable polymorph 
(e) Complexation 
Complexation  is  the association  between  two  or  more 
molecules  to  form  a  non  bonded  entity with  a  well  
defined stichiometry. Complexation relies on relatively weak 
forces such as London forces, hydrogen bonding and 
hydrophobic interactions. Ex. of complexing agents are; 
chelates- EDTA, EGTA, molecular complexes- polymers, 
inclusion complexes cyclodextrins22,23. 
(f) Solubilisation by Surfactants 
Surfactants are molecules with distinctpolar and nonpolar 
regions.  Most surfactants consist of a hydrocarbon segment 
connected to a polar group. The polar group can be anionic, 
cationic, zwitterionic or non-ionic.  When smallpolar 
molecules are added they can accumulate in the hydrophobic 
core of the micelles.  This process of solubilization  is very 
important in industrial and biological processes.  The  
presence  of  surfactants may  lower  the  surface  tension  
but increases  solubility  of  drug  within  an organic solvent. 
II CHEMICAL MODIFICATIONS16,33 
(a) Salt Formation  
 Salt  formation  is  the  most  common and  effective  method  
of  increasing solubility  and  dissolution  rates  of  acidic and  
basic  drugs.  Acidic or basic drug converted into salt having 
more solubility than respective drug.  Ex. Aspirin, 
Theophylline, Barbiturates. 
(b) Co-crystallization 
New approach available for the enhancement of drug 
solubility is through the application of the co-crystals, it is 
also referred as molecular complexes. A co-crystals may  be  
defined as  crystalline material  that  consist of  two or more 
molecular (and electrical neutral) species  held  together  by  
non-covalent forces.  It  can be prepared by evaporation of  a  
heteromeric  solution  or  by  grinding the  components  
together  or  by sublimation,  growth  from  the  melt  and 
slurry  preparation.  It  is  increasingly important  as  an  
alternative  to  salt formation,  particularly  for  neutral 
compounds20,24. 
(c) Co-solvent  
It  is  well-known  that  the addition of an organic co-solvent 
to water can  dramatically  change  the  solubility  of drugs.  
Weak electrolytes and nonpolar molecules have poor water 
by the adding water miscible solvent in which the drug has 
good solubility the solubility of a poorly water soluble drug 
can be increased frequently known as co solvents also 
known as solvent blending. Co-solvent formulations of 
poorly soluble drugs can be administered orally and 
parenterally29-30. It is also commonly referred to as solvent 
blending. Most co solvents have hydrogen bond donor 
and/or acceptor groups as well as small hydrocarbon 
regions. Their hydrophilic hydrogen bonding groups ensure 
water miscibility, while their hydrophobic hydrocarbon 
regions interfere with waters hydrogen bonding network, 
reducing the overall intermolecular attraction of water19,25. 
By disrupting waters self-association, co solvents reduce 
waters ability to squeeze out nonpolar, hydrophobic 
compounds, thus increasing solubility.  
Advantages 
1. Compared to other solubilisation approaches very high 
drug concentrations of poorly soluble compounds can be 
dissolved.  
2. Co- Solvents can enhance the solubility of poorly soluble 
compounds several thousand times compared to the 
aqueous solubility of the drug alone. Weak electrolytes and 
nonpolar molecules have poor water solubility and it can be 
improved by altering polarity of the solvent.  
3. It is Simple and rapid method to formulate and produce.  
(d) Hydrotropy33 
 It  designates  to  increase in  solubility  in water  due  to  
presence  of large  amount  of  additives.It improves 
solubility by complexation involving weak interaction  
between  hydrophobic  agents (Sodium benzoate,  sodium 
alginate, urea) and  solute.  Ex.Sublimation ofTheophylline 
with Sodium acetate and Sodium alginate26. 
(e) Solubilising agents 
The solubility of poorly soluble drug can also be improved by 
various solubilizing materials. Ex. PEG 400 is improving the 
solubility of hydrochlorothiazide. 
(f) Nanotechnology Approach 
Nanotechnology  will  be  used  to  improve drugs  that  
currently  have  poor  solubility. Nanotechnology  refers  
broadly  to  the study and use of materials and structures at  
the  nanoscale  level  of  approximately 100  nanometres  
(nm)  or  less20. 
SOLID DISPERSION  
Solid dispersions are one of the most successful strategies to 
improve drug release of poorly soluble drugs. Sekiguchi and 
Obi were the first to describe on solid dispersions in 1961. 
Solid dispersion is one of the important strategies to tackle 
dissolution rate limited oral absorption of poorly soluble 
compounds. Formulation of poorly soluble compounds as 
solid dispersions might lead to particle size reduction, 
improved wetting, reduced agglomeration, changeability in 
the physical state of the drug molecules and possibly a 
dispersion in the molecular level, according to the physical 
state of the solid dispersion. The term solid dispersion refers 
to a group of solid products consisting of at least two 
different components, generally a hydrophilic matrix and a 
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hydrophobic drug. The matrix can be either crystalline or 
amorphous24,25. The drugs can be dispersed molecularly, 
either in amorphous particles (clusters) or in crystalline 
particles. Solid dispersion Solid dispersions are classified by 
various ways, on the basis of their solid state structure as 
well as on the basis of carrier used. It is relevant to classify 
various systems of solid dispersion as per as their fast 
release mechanisms are concerned. Riegelman and Chiou 
classified solid dispersions into the following six 
representative types: Simple eutectic mixtures, amorphous 
precipitations in a crystalline carrier, solid solutions, glass 
solutions and glass suspensions, compound or complex 
formation, and combinations of the previous five types.  
Classification of Solid Dispersion12,27,33  
Solid dispersion classified in 3 groups. 
1. First generation solid dispersions: In first generation solid 
dispersion, formulation of eutectic mixtures or molecular 
dispersion improved the rate of drug release which in turn 
increases the bioavailability of poorly water soluble drugs. 
Disadvantage related formulation of crystalline solid does 
not release drug quickly. Example: Crystalline carriers: Urea, 
Sugars and Organic acids. 
2. Second generation solid dispersion: In second generation 
we use amorphous state of carrier which improves drug 
release; likes fully synthetic polymers include povidone 
(PVP), polyethyleneglycols (PEG) and polymethacrylates. 
Natural product based polymers are mainly composed by 
cellulose derivatives, such as hydroxypropyl methylcellulose 
(HPMC), ethylcellulose or hydroxypropyl cellulose or starch 
derivates, like cyclodextrins. 
3. Third generation solid dispersion: In third generation we 
use carrier which have surface activity and self-emulsifying 
property. The surfactants decrease the recrystallization of 
drug and thus improve the solubility of drug. Example: 
Surface active self-emulsifying carriers: Poloxamer 408, 
Tween 80, and Gelucire 44/1427.  
Types of solid dispersions 16-32 
a.  Simple  eutectic mixture:  An  eutectic mixture of a 
sparingly water soluble drug and a highly water soluble 
carrier may be regarded  thermodynamically  as  an 
intimately blended physical mixture of  its two  crystalline  
component.  The increase in surface area is mainly 
responsible for increased rate of dissolution. This led to a 
conclusion that the increase in dissolution was mainly due to 
decreased particle size.  
b. Solid solutions: Solid solutions consist of a solid solute 
dissolved in a solid solvent. A mixed crystal is formed 
because the two components crystallize togetherin a 
homogenous one-phase system. Hence,  this  system would  
be  expected  to yield  much  higher  rates  of  dissolution 
than simple eutectic systems 
c. Glass  solution  of  suspension:  A  glass solution is a 
homogenous system in which a  glassy  or  a  vitreous  of  the  
carrier solubilizer  drug  molecules  in  its  matrix. PVP  
dissolved  in  organic  solvents undergoes  a  transition  to  a  
glassy  state upon evaporation of the solvent.  
d.  Compound  or  complex  formation: This  system  is  
characterized  by complexation  of  two  components  in  a 
binary  system  during  solid  dispersion preparation.  The  
availability  of  the  drug from  the  complex  is  dependent  
on  the solubility  dissociation  constant  and  the intrinsic 
absorption rate of the complex31. 
e. Amorphous precipitation: Amorphous precipitation occurs 
when drug precipitates as an amorphous form in the inert 
carrier.  The  higher  energy  state  of the drug in this system 
generally produces much  greater  dissolution  rates  than  
the corresponding  crystalline  forms  of  the drug19,27. 
Advantages of solid dispersion 
1. Reduction in particle size: different carrier use in solid 
dispersion reduces particle size of drug particle which 
improve solubility and bioavailability.  
2. Improve wettability of particle: solid dispersion improves 
wettability of particle.  
3. Improve porosity: Solid dispersions containing linear 
polymers produce larger and more porous particles than 
those containing reticular polymers and therefore, result in a 
higher dissolution rate  
4. Improve dissolution which ultimately improves the 
solubility and bioavailability.  
Disadvantages of solid dispersion 
1. Instability due moisture content.  
2. Difficulty in incorporating into formulation of dosage 
forms 
Manufacturing methods of solid dispersion  
1. Solvent evaporation method: In solvent evaporation 
method we dissolve both the drug and the carrier in a 
common solvent and then evaporate the solvent under 
vacuum to produce a solid solution. Tachibechi and 
Nakumara were the first to dissolve both the drug (β-
carotene and the carrier PVP) in a common solvent and then 
evaporate the solvent under vacuum to produce a solid 
dispersion. Commonly use solvent such as ethanol, 
chloroform, or a mixture of ethanol and dichloromethane. In 
some case cosolvant may use because large volume of 
solvents as well as heating may be required to enable 
complete dissolution of drug and carrier. The main 
advantage of the solvent method is thermal decomposition of 
drugs or carriers can be prevented because of the relatively 
low temperatures required for the evaporation of organic 
solvents. The disadvantages of solvent method such as; 
expensive, ecological, and difficult to find common and 
removable solvents, difficulty in completely removing liquid 
solvent, difficulty of reproducing crystal form24,27.  
2. Fusion/melting method39: The physical mixture of a drug 
and a water-soluble carrier was heated directly until it gets 
melted. The melted mixture was then cooled and solidified 
rapidly in an ice bath under rigorous stirring. The final solid 
mass was crushed, pulverized, and sieved which improve the 
solubility and bioavailability of drug. Limitation regarding 
this method is at high temperature many drug may get 
degraded.  
3. Hot melt extrusion30-38: HME can be simply defined as 
the process of forming a new material (the extrude) by 
forcing it through an orifice or die under controlled 
conditions, such as temperature, mixing, feed-rate and 
pressure. HME differs from simple extrusion in that, 
polymer, drug and excipients blends are mixed thoroughly in 
the molten state in this process, needing no solvents for 
granulation. The molten polymer serves as the thermal 
binder19,23.  
Advantage of HME  
1. Improve the solubility and bioavailability of poorly soluble 
compounds. 
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 2. Processing in the absence of solvents and water.  
3. Economical process with reduced production time, fewer 
processing steps, and a continuous operation. 
 4. Uniform dispersion of fine particle occurs.  
5. Good stability at varying pH and moisture levels. 
 6. Safe application in humans due to their non swellable and 
water insoluble nature.  
Disadvantages of HME 
1. Not applicable to heat sensitive material.  
2. Limited number of available polymer.  
3. This method requires high energy input.  
Application of HME 
1) Masking the bitter taste of an active drug.  
2) Formation of polymer-drug solutions/dispersions which 
increased drug solubility and increased drug dissolution 
rate.  
3) Formulation of controlled release dosage forms (including 
implants).  
4) Formulation of targeted release dosage forms.  
4. Super Critical Fluid Method: (SCF) Super critical fluid is 
fluid which exists as single fluid above its critical 
temperature and pressure.SCF shows the properties of both 
a liquid and a gas above its critical condition. It is safe, 
environmentally friendly, and economical. The low operating 
conditions (temperature and pressure) make SCFs attractive 
for pharmaceutical research. At near-critical temperatures, 
SCFs are high compressible, allowing moderate changes in 
pressure to greatly alter the density and mass transport 
characteristics of a fluid that largely determine its solvent 
power. Once the drug particles are solubilised within SCF, 
they may be re-crystallized at greatly reduced particle 
sizes27.Carbon dioxide is the most commonly used SCF 
because it is chemically inert, non toxic and non flammable. 
Other supercritical solvents include nitrous oxide, ethylene, 
propylene, propane, npentane, ethanol, ammonia, and water.  
5. Liquisolid method: In liquisolid technique liquid may be 
transfer into free flowing, readily compressible and 
apparently dry powder by simple blending with selected 
carrier and coating material. The liquid portion which can be 
liquid drug, drug suspension or drug solution in a suitable 
non volatile liquid vehicle can be converted into acceptably 
flowing and compressible powders by blending with selected 
powder excipients. The acceptable flowing and compressible 
powder form of liquid medication is liquisolid compact. The 
liquisolid is newer and promising approach because of 
simple manufacturing process, low production coast, and 
applicable for industry due to good flow and compact 
property of liquisolid formulation28-33. When the drug 
dissolved in the liquid vehicle is incorporated into a carrier 
material which has a porous surface and closely matted 
fibers in its interior as cellulose, both absorption and 
adsorption take place; i.e. the liquid initially absorbed in the 
interior of the particles is captured by its internal structure, 
and after the saturation of this process, adsorption of the 
liquid onto the internal and external surfaces of the porous 
carrier particles occur. Then, the coating material having 
high adsorptive properties and large specific surface area 
gives the liquisolid system the desirable flow 
characteristics19,23.  
The wettability of the compacts by the dissolution media is 
one of the proposed mechanisms for explaining the 
enhanced dissolution rate from the liquisolid compacts. Non-
volatile solvent present in the liquisolid system facilitates 
wetting of drug particles by decreasing interfacial tension 
between dissolution medium and tablet surface. 
Shah, D., Patel, B., & Shah, C. Nanosuspension technology: a 
innovative slant for drug delivery system and permeability enhancer 
for poorly water soluble drugs. Journal of Drug Delivery and 
Therapeutics, 2015; 5(1):10-23. 
https://doi.org/10.22270/jddt.v5i1.995 
Jaiswal, P., Kesharwani, S., Kesharwani, R., & Patel, D. (2016). 
Ethosome: a new technology used as topical & transdermal delivery 
system. Journal of Drug Delivery and Therapeutics, 6(3), 7-17. 
https://doi.org/10.22270/jddt.v6i3.1245 
Bhirud, Y., & Phalak, H., Advances in solid dispersion technology and 
its applications in the development of solid dosage forms. Journal of 
Drug Delivery and Therapeutics, 2016; 6(6):40-47. 
https://doi.org/10.22270/jddt.v6i6.1316 
Classification of liquisolid system26-40 
Classification based on type of liquid medication contain 
there in: 
1. Powdered drug solutions.  
2. Powdered drug suspensions.  
3. Powdered liquid drugs.  
Classification based on technique use for formulation 
1. Liquisolid compacts.  
2. Liquisolid Microsystems 
Advantages of liquisolid method: 
1. Method improves the solubility and bioavailability of 
orally administered water insoluble or poorly soluble drugs.  
2. Method is applicable in industry.  
3. Useful for the formulation of oily drugs/liquid drugs.  
4. By using different carrier and additives drug release can 
be modified like PVP, PEG 60000, Hydroxy Propyl Methyl 
Cellulose and Eudragit etc.  
5. A number of poorly soluble drugs can be formulated in to 
the system. 
 6. Production cost is low compared to that of preparation of 
soft gelatin capsules  
7. This system is specifically for the powdered liquid 
medications. 
 Disadvantages of liquid solid method 
1) High solubility of drug in the non-volatile liquid drugs for 
the improvement of dissolution rate and bioavailability. 
 2) It requires recipients of high adsorption properties and 
high specific surface area.  
3) It is not applicable to high dose insoluble drugs (>100 
mg).  
4) During compression sometimes liquid drug may be 
squeezed out of the tablet result in improper hardness21-27. 
6. Self-emulsifying system: SEDDS or SMEDDS are the 
important method to improve the solubility and 
bioavailability of poorly water soluble drug. SEDDS are 
define as isotropic mixture natural or synthetic oils, solid or 
liquid surfactant, or alternative, one or more hydrophilic 
solvent and co-solvent/surfactant22-40.  SEDDSs typically 
produce emulsions with a droplet size between 100–300 nm 
while self-micro-emulsifying drug delivery systems 
Pawar et al                                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(2):583-590     
ISSN: 2250-1177                                                                                  [588]                                                                                 CODEN (USA): JDDTAO 
(SMEDDSs) form transparent micro-emulsions with a 
droplet size of less than 50 nm. Upon mild agitation followed 
by dilution in aqueous media, such as GI fluids, these systems 
can form fine oil−in−water (o/w) emulsions or micro-
emulsions (SMEDDS).Self emulsifying formulations spread 
readily in the GI tract, and the digestive motility of the 
stomach and the intestine provide the agitation necessary for 
self-emulsification23,27. When compared with emulsions, 
which are sensitive and metastable dispersed forms, SEDDS 
are physically stable formulations that are easy to 
manufacture.  
Composition of SEDDS:36-37 The composition of self 
emulsifying system is simple combination of drug, oils, 
surfactant and co surfactant or co-solvent. The self-
emulsifying process depends on: The nature of the oil and 
surfactant. The concentration of surfactant The temperature 
at which self-emulsification occurs 
1. Oils: Oils can solubilise the lipophilic drug in a specific 
amount. Oil can facilitate self-emulsifying and increase the 
fraction of lipophilic drug transported via the intestinal 
lymphatic system, increasing absorption from GIT. Example; 
olive oil, oleic oil, sesame oil. 
 2. Surfactant: Non-ionic surfactant with high 
hydrophiliclipophilic balances (HLB) value is used in the 
formulation of SEDDS. High HLB and hydrophilicity of 
surfactant assists the immediate formulation of o/w droplets 
and rapid spreading of formulation in the aqueous media. 
Example; Tween, Labrasol, cremophore etc. 
3. Co-surfactant/ co-solvent: Dissolve large amount of 
hydrophilic surfactant or hydrophobic drugs in lipid phase. It 
increases fluidity of the interfacial film. Example: ethanol, 
propylene glycol, polyethylene glycol, polyoxyethlene, 
propylene carbonate tetrahydrofurfuryl alcohol, Glycofurol 
etc. Mechanism of self emulsification: Self-emulsification 
takes place when the entropy change favouring dispersion is 
greater than the energy required to increase the surface area 
of the dispersion23-37. 
The type of self emulsifying dosage form includes Self 
emulsifying tablet, capsule, pellets, solid dispersion, powder 
ets. Method use for preparation of self emulsifying system is 
melt granulation, spray drying, capsule filling, and melt 
extrusion ets.  
Advantages of Self Emulsifying system19,23  
a. Improvement in oral bioavailability enabling reduction in 
dose. 
b. Ease of manufacturing and scale up.  
c. High drug loading efficiency. 
d. Protection of drugs from the gut environment  
e. More consistent and reproducible profile of drug 
absorption and blood time profile.  
Disadvantages of Self Emulsifying system 
a. High surfactant concentration irritates the GIT.  
b. Chemical instability of drug and surfactant in formulation 
7.Complexation: Complexation is the association between 
two or more molecules to form a non bonded entity with a 
well definedstochiometry. In Complexation relatively weak 
forces such as London forces, hydrogen bonding and 
hydrophobic interactions involved.  
 
 
Two type of complex available 20-35 
1. Stacking complexes: It is driven by association of non 
polar area of drug and complexes agent this results in 
exclusion of the non polar area from contact with water, 
thereby reducing total energy of the system. Stacking can be 
homogeneous or mixed, but results in clear solution.  
2. Inclusion complexes: It is formed by the inserting the 
nonpolar molecule or the nonpolar region of one molecule 
into the cavity of another molecule or group of molecules. 
There are no forces involved between them and therefore 
there are no bond is also called as no-bond complexes33-36. 
Cyclodextrins are a group of cyclic oligosaccharides obtained 
from enzymatic degradation of starch. The three major 
cyclodextrins α, ß, and γ-CD are composed of six, seven, and 
eight D-(+) -glucopyranose units13,14. Cyclodextrins have a 
hydrophilic exterior and a hydrophobic internal cavity. 
Cyclodextrine and their derivatives commonly use in 
Complexation. They form complex with drug and improve 
the solubility and bioavailability of poorly soluble drug. 
Derivatives of R-cyclodextrin with increased water solubility 
(e.g. hydroxypropyl-Rcyclodextrin HP-R-CD) are most 
commonly used in pharmaceutical formulation. The forces 
driving complexation were attributed to: 
1. The exclusion of high energy water from the cavity. 
2. The release of ring strain particularly in the case of –CD. 
3. Van Der Val’s interactions. 
4. Hydrogen and hydrophobic bindings.  
Solid inclusion complexes can be prepared by using 
following methods 
1. Kneading method: This method is based on impregnating 
the CDs with little amount of water or hydro alcoholic 
solutions to converted into a paste. The drug is then added to 
the above paste and kneaded for a specified time. The 
kneaded mixture is then dried and passed through sieve. 
 2. Co-precipitation: In this method, in the solution of CDs 
the required amount of drug is added. The complex kept 
under magnetic agitation with controlled process 
parameters. The complex is protected from the light. The 
formed precipitate is separated by vacuum filtration and 
dried at room temperature in order to avoid the loss of the 
structure water from the inclusion complex. This method is 
applicable to industry 6,13.  
3. Physical blending method: It is simple trituration 
method. In this method the CDs and drug are mixed together 
thoroughly by trituration in a mortar and passes through 
appropriate sieve to get the desired particle size in the final 
product11.  
4. Neutralization method: In this method precipitation of 
inclusion compounds by neutralization technique take place 
.in this dissolve the drug in alkaline solutions like 
sodium/ammonium hydroxide and mix with an aqueous 
solution of CDs. The clear solution is obtained. This solution 
is neutralising under agitation using hydrochloric acid 
solution till reaching the equivalence point. A white 
precipitate is being formed at this moment. This precipitate 
is filtered and dried13,14.  
5. Milling/Co-grinding technique: By using this method a 
solid binary inclusion compounds of drug and CD is 
prepared. In this method Drug and CDs are mixed intimately 
and the physical mixture is introduced in an oscillatory mill 
and grinded for suitable time. Ball mill is also use for 
preparation of binary complex13,14. 
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 6. Lyophilisation/ Freeze drying technique: 
Lyophilisation/ freeze drying technique is considered as a 
suitable technique to get a porous, amorphous powder with 
high degree of interaction between drug & CD13,14,15. This 
technique is suitable for thermo labile substances. In this 
technique, the solvent system from the solution is eliminated 
through a primary freezing and subsequent drying of the 
solution containing both drug & CD at reduced pressure is 
form.  
7. Microwave irradiation method: In this technique the 
microwave irradiation reaction between drug and 
complexing agent takes place using a microwave oven. The 
drug and CD in definite molar ratio are dissolved in a 
mixture of water and organic solvent in a specified 
proportion into a round bottom flask. The mixture is reacted 
for short time of about one to two minutes at 60ºC in the 
microwave oven16,17. After the reaction completes, adequate 
amount of solvent mixture is added to the above reaction 
mixture to remove the residual, uncomplexed free drug and 
CD. The precipitate so obtained is separated using whatman 
filter paper, and dried in vacuum oven at 40ºC for 48 hrs. 
Microwave irradiation method is a novel method for 
industrial scale preparation due to its major advantage of 
shorter reaction time and higher yield of the product31. 
 8. Supercritical antisolvent technique: In the supercritical 
fluid antisolvent technique, carbon dioxide is used as anti-
solvent for the solute but as a solvent with respect to the 
organic solvent. The use of supercritical carbon dioxide is 
advantageous as its low critical temperature and pressure 
makes it attractive for processing heatlabile 
pharmaceuticals. This method is important for improving 
bioavailability of pharmaceutically active compounds. 
Supercritical carbon dioxide due to its properties of 
improved mass transfer and increased solvating power it 
proved as a new complexation medium22,18. In this 
technique, first, drug and CD are dissolved in a good solvent 
then the solution is fed into a pressure vessel under 
supercritical conditions, through a nozzle (i.e. sprayed into 
supercritical fluid anti-solvent). When the solution is 
sprayed into supercritical fluid antisolvent, the anti-solvent 
rapidly diffuses into that liquid solvent as the carrier liquid 
solvent counter diffuses into the anti-solvent29-30. Because of 
the supercritical fluid expanded solvent has lower solvent 
power than the pure solvent, the mixture becomes 
supersaturated resulting in the precipitation of the solute 
and the solvent is carried away with the supercritical fluid 
flow.  
CONCLUSION 
Dissolution of drug is the rate determining step for oral 
absorption of the poorly water soluble drugs, which can 
subsequently affect the in vivo absorption of drug. Because 
of solubility problem of many drugs the bioavailability of 
them gets affected and hence solubility enhancement 
becomes necessary. The basic approaches followed by all the 
currently available technologies engaged in the solubility 
and dissolution enhancement is to maximize the 
bioavailability and therapeutic efficacy. To overcome the 
solubility problem various solubility enhancement methods 
are develop today which is industrial applicable. By using 
newer techniques which are discussed above it is possible to 
improve solubility of poorly water soluble drugs. By this 
article we conclude that, Solubility is the most important 
physical characteristic of a drug for its oral bioavailability, 
formulation, development of different dosage form of 
different drugs, therapeutic efficacy of the drug and for 
quantitative analysis. Proper selection of solubility 
enhancement method is the key to ensure the goals of a good 
formulation like good oral bioavailability, reduce frequency 
of dosing and better patient compliance combined with a low 
cost of production. The different techniques described above 
alone or in combination can be used to enhance the solubility 
of the drug. Solubility can be enhanced by many techniques 
and number of folds increase in solubility. Because of 
solubility problem of many drugs the bioavailability of them 
gets affected and hence solubility enhancement becomes 
necessary. It is now possible that to increase the solubility of 
poorly soluble drugs with the help of various techniques as 
mentioned above. 
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